|
 |
|
|||||||
|
|||||||||
Diabetes 54:1040-1047, 2005
© 2005 by the American Diabetes Association, Inc.
In Vivo Control of Diabetogenic T-Cells by Regulatory CD4+CD25+ T-Cells Expressing Foxp3
From the Hagedorn Research Institute, Gentofte, Denmark
To understand the ability of regulatory T-cells to control diabetes development in clinically relevant situations, we established a new model of accelerated diabetes in young DP-BB rats by transferring purified T-cells from DR-BB rats made acutely diabetic. Transfer of 3, 5, 10, or 23 million pure in vitro–activated T-cells accelerated diabetes onset in >90% of the recipients, with the degree of acceleration being dosage dependent. Cotransfer of unfractionated leukocytes from healthy donors prevented diabetes. Full protection was achieved when protective cells were transferred 3–4 days before diabetogenic cells, whereas transfer 2 days before conferred only partial protection. Protection resided in the CD4+ fraction, as purified CD4+ T-cells prevented the accelerated diabetes. When CD25+ cells were depleted from these cells before they were transferred, their ability to prevent diabetes was impaired. In contrast, two million CD4+CD25+ cells (expressing Foxp3) prevented the accelerated diabetes when transferred both before and simultaneously with the diabetogenic T-cells. In addition, 2 million CD4+CD25+ T-cells prevented spontaneous diabetes, even when given to rats age 42 days, whereas 20 million CD4+CD25– cells (with low Foxp3 expression) were far less effective. We thus demonstrated that CD4+CD25+ cells exhibit powerful regulatory potential in rat diabetes.
Address correspondence and reprint requests to Helle Markholst, MD, Hagedorn Research Institute, Niels Steensens Vej 6, DK-2820, Gentofte, Denmark. E-mail: hmar{at}hagedorn.dk
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Barath, M. Aleksza, T. Tarr, S. Sipka, G. Szegedi, and E. Kiss Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus Lupus, July 1, 2007; 16(7): 489 - 496. [Abstract] [PDF]
|
|
|
|
 |
|
 J. M. Fuller, A. E. Kwitek, T. J. Hawkins, D. H. Moralejo, W. Lu, T. D. Tupling, A. J. MacMurray, G. Borchardt, M. Hasinoff, and A. Lernmark Introgression of F344 Rat Genomic DNA on BB Rat Chromosome 4 Generates Diabetes-Resistant Lymphopenic BB Rats Diabetes, December 1, 2006; 55(12): 3351 - 3357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-L. Hillebrands, B. Whalen, J. T. J. Visser, J. Koning, K. D. Bishop, J. Leif, J. Rozing, J. P. Mordes, D. L. Greiner, and A. A. Rossini A Regulatory CD4+ T Cell Subset in the BB Rat Model of Autoimmune Diabetes Expresses Neither CD25 Nor Foxp3 J. Immunol., December 1, 2006; 177(11): 7820 - 7832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Geoffrey, S. Jia, A. E. Kwitek, J. Woodliff, S. Ghosh, A. Lernmark, X. Wang, and M. J. Hessner Evidence of a Functional Role for Mast Cells in the Development of Type 1 Diabetes Mellitus in the BioBreeding Rat J. Immunol., November 15, 2006; 177(10): 7275 - 7286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Tischner, A. Weishaupt, J. v. d. Brandt, N. Muller, N. Beyersdorf, C. W. Ip, K. V. Toyka, T. Hunig, R. Gold, T. Kerkau, et al. Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis Brain, October 1, 2006; 129(10): 2635 - 2647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bruder, A. M. Westendorf, W. Hansen, S. Prettin, A. D. Gruber, Y. Qian, H. von Boehmer, K. Mahnke, and J. Buer On the Edge of Autoimmunity: T-Cell Stimulation by Steady-State Dendritic Cells Prevents Autoimmune Diabetes Diabetes, December 1, 2005; 54(12): 3395 - 3401. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |